Cargando…
The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is characterized by thrombosis (arterial, venous, small vessel) and/or pregnancy morbidity occurring in patients with persistently positive antiphospholipid antibodies (aPL). Catastrophic APS is the most severe form of the disease, characterized by multiple organ thro...
Autores principales: | Erkan, Doruk, Salmon, Jane E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805354/ https://www.ncbi.nlm.nih.gov/pubmed/27020721 http://dx.doi.org/10.4274/tjh.2015.0197 |
Ejemplares similares
-
Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay
por: Sciascia, Savino, et al.
Publicado: (2016) -
The ABCs of antiphospholipid syndrome
por: Bahar Keleşoğlu Dinçer, Ayşe, et al.
Publicado: (2023) -
Incidence of Antiphospholipid Syndrome: Is Estimation Currently Possible?
por: Ioannou, Yiannis, et al.
Publicado: (2023) -
Clinical Management of Thrombotic Antiphospholipid Syndrome
por: Tumian, Nor Rafeah, et al.
Publicado: (2022) -
Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome
por: Stoots, Sarah Abramson, et al.
Publicado: (2019)